Drug Development Regulatory Pathways Across the Globe
Join this event to explore examples of how biotech companies navigated regulatory hurdles.
Presentations and a panel discussion will assess key differences in global regulatory processes, especially between the U.S. and Canada, and will dive deeper into start-up regulatory strategy and how companies can acquire government approval for their products across different jurisdictions.
Clarissa Jepson (Program Analyst, Capital Access) and Gaayatiri Pushparaj (Program Analyst, Technology Adoption) from OBIO® will be attending this event.